110 related articles for article (PubMed ID: 17310074)
21. Comparison of three preclinical models for nausea and vomiting assessment.
Goineau S; Castagné V
J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617
[TBL] [Abstract][Full Text] [Related]
22. Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs.
Costall B; Domeney AM; Naylor RJ; Tattersall FD
Neuropharmacology; 1987 Sep; 26(9):1321-6. PubMed ID: 2890117
[TBL] [Abstract][Full Text] [Related]
23. Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone.
Campos D; Pereira JR; Reinhardt RR; Carracedo C; Poli S; Vogel C; Martinez-Cedillo J; Erazo A; Wittreich J; Eriksson LO; Carides AD; Gertz BJ
J Clin Oncol; 2001 Mar; 19(6):1759-67. PubMed ID: 11251007
[TBL] [Abstract][Full Text] [Related]
24. Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets.
Yamakuni H; Sawai-Nakayama H; Imazumi K; Maeda Y; Matsuo M; Manda T; Mutoh S
Eur J Pharmacol; 2002 May; 442(3):273-8. PubMed ID: 12065081
[TBL] [Abstract][Full Text] [Related]
25. Using telemetry to automate the detection of emesis in the ferret: new vistas for delayed emesis assessment.
Goineau S; Rompion S; Guillaume P; Barrais L; Castagné V
J Pharmacol Toxicol Methods; 2013; 68(1):160-5. PubMed ID: 23578691
[TBL] [Abstract][Full Text] [Related]
26. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate produces delayed emesis in dogs: a potential model of delayed emesis induced by chemotherapy.
Fukui H; Yamamoto M
Eur J Pharmacol; 1999 May; 372(3):261-7. PubMed ID: 10395021
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
[TBL] [Abstract][Full Text] [Related]
29. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM
Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022
[TBL] [Abstract][Full Text] [Related]
30. Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret.
Tsuchiya M; Fujiwara Y; Kanai Y; Mizutani M; Shimada K; Suga O; Ueda S; Watson JW; Nagahisa A
Pharmacology; 2002 Nov; 66(3):144-52. PubMed ID: 12372904
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin-induced emesis in the Ferret: a new animal model.
Florczyk AP; Schurig JE; Bradner WT
Cancer Treat Rep; 1982 Jan; 66(1):187-9. PubMed ID: 7198011
[TBL] [Abstract][Full Text] [Related]
32. The actions of fenfluramine and interaction with 5-HT3 receptor-antagonists to inhibit emesis in the ferret.
Costall B; Naylor RJ; Tattersall FD
J Pharm Pharmacol; 1990 Feb; 42(2):94-101. PubMed ID: 1972409
[TBL] [Abstract][Full Text] [Related]
33. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
[TBL] [Abstract][Full Text] [Related]
34. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
35. Double-blind, multicenter, randomized trial to compare the effect of two doses of adrenocorticotropic hormone versus placebo in controlling delayed emesis after high-dose cisplatin in adult patients with cancer.
Passalacqua R; Cocconi G; Caminiti C; Silingardi V; Bella MA; Bichisao E; Michiara M; Malavasi V; Donati D; Di Costanzo F; Rocca A; Di Sarra S; Scaglione F; Fraschini F
J Clin Oncol; 1997 Jun; 15(6):2467-73. PubMed ID: 9196163
[TBL] [Abstract][Full Text] [Related]
36. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
Navari RM; Reinhardt RR; Gralla RJ; Kris MG; Hesketh PJ; Khojasteh A; Kindler H; Grote TH; Pendergrass K; Grunberg SM; Carides AD; Gertz BJ
N Engl J Med; 1999 Jan; 340(3):190-5. PubMed ID: 9917226
[TBL] [Abstract][Full Text] [Related]
37. Serotonin-independent model of cisplatin-induced emesis in the ferret.
Rudd JA; Cheng CH; Naylor RJ
Jpn J Pharmacol; 1998 Nov; 78(3):253-60. PubMed ID: 9869258
[TBL] [Abstract][Full Text] [Related]
38. Characterization of lipopolysaccharide-induced emesis in conscious piglets: effects of cervical vagotomy, cyclooxygenase inhibitors and a 5-HT(3) receptor antagonist.
Girod V; Bouvier M; Grélot L
Neuropharmacology; 2000 Sep; 39(12):2329-35. PubMed ID: 10974316
[TBL] [Abstract][Full Text] [Related]
39. Further studies of the antiemetic activity of granisetron against whole body X-irradiation or cisplatin-induced emesis in the ferret.
Marr HE; Davey PT; Boyle EA; Blower PR
Pharmacology; 1994 May; 48(5):283-92. PubMed ID: 8016189
[TBL] [Abstract][Full Text] [Related]
40. Action of Bacopa monnieri to antagonize cisplatin-induced emesis in Suncus murinus (house musk shrew).
Ullah I; Subhan F; Lu Z; Chan SW; Rudd JA
J Pharmacol Sci; 2017 Apr; 133(4):232-239. PubMed ID: 28363413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
